Predictive model of declining glomerular filtration rate in type 2 diabetes mellitus with poorly glycemic control: Integration of RAAS and TGFB polymorphisms with clinical risk factors in the Jambi Malay population

Authors

  • Anggelia Puspasari Department of Medical Biology and Biochemistry, Faculty of Medicine and Health Sciences, Universitas Jambi
  • Elfiani Department of Nephrology and Hypertension, Raden Mattaher General Hospital, Faculty of Medicine and Health Sciences, Universitas Jambi
  • Citra Maharani Department of Medical Biology and Biochemistry, Faculty of Medicine and Health Sciences, Universitas Jambi
  • Ahmad Syauqy Department of Medical Biology and Biochemistry, Faculty of Medicine and Health Sciences, Universitas Jambi
  • Erny Kusdiyah Department of Public Health, Faculty of Medicine and Health Sciences, Universitas Jambi
  • Nyimas Natasha Ayu Shafira Department of Medical Education, Faculty of Medicine and Health Sciences, Universitas Jambi
  • Amelia Dwi Fitri Department of Medical Education, Faculty of Medicine and Health Sciences, Universitas Jambi

DOI:

https://doi.org/10.22437/proca.v1i2.50317

Keywords:

Type 2 diabetes mellitus; diabetic kidney diseases; declining GFR; RAAS; TGFB; genetic polymorphism; poorly glycemic control; Malay population

Abstract

Background: Diabetic kidney disease (DKD) is a major complication of type 2 diabetes mellitus (T2DM) and a leading cause of end-stage renal disease worldwide. Despite optimal glycemic and blood pressure control, many patients experience renal decline, suggesting a role for genetic factors. Objective: To develop a predictive model integrating clinical and genetic parameters to identify individuals at risk of declining glomerular filtration rate (GFR) among Malay Jambi patients with poorly controlled T2DM. Methods: A cross-sectional study of 62 patients was conducted using ACE rs4343 and TGFB1 rs1800470 genotyping by Tetra-ARMS PCR. Declining renal function was defined as eGFR <60 mL/min/1.73 m² (KDIGO 2024). Logistic regression and ROC analyses assessed model performance. Results: Older age and higher blood pressure were associated with reduced GFR. The TGFB1 rs1800470 TT and ACE rs4343 AG genotypes significantly increased the risk of renal decline (adjusted OR 7.79 and 5.98, respectively; p < 0.05). The integrated clinical–genetic model achieved the highest discrimination (AUC = 0.859; sensitivity 78.9%; specificity 88.4%). Conclusion: Integrating ACE and TGFB1 genotypes with clinical factors enhances DKD risk prediction and supports early genotype-informed interventions. This approach strengthens population-specific precision nephrology in Indonesia and provides a foundation for future polygenic risk model development.

Downloads

Download data is not yet available.

Author Biographies

Anggelia Puspasari, Department of Medical Biology and Biochemistry, Faculty of Medicine and Health Sciences, Universitas Jambi

Department of Medical Biology and Biochemistry, Faculty of Medicine and Health Sciences, Universitas Jambi

Elfiani, Department of Nephrology and Hypertension, Raden Mattaher General Hospital, Faculty of Medicine and Health Sciences, Universitas Jambi

Department of Nephrology and Hypertension, Raden Mattaher General Hospital, Faculty of Medicine and Health Sciences, Universitas Jambi

Citra Maharani, Department of Medical Biology and Biochemistry, Faculty of Medicine and Health Sciences, Universitas Jambi

Department of Medical Biology and Biochemistry, Faculty of Medicine and Health Sciences, Universitas Jambi

Ahmad Syauqy, Department of Medical Biology and Biochemistry, Faculty of Medicine and Health Sciences, Universitas Jambi

Department of Medical Biology and Biochemistry, Faculty of Medicine and Health Sciences, Universitas Jambi

Erny Kusdiyah, Department of Public Health, Faculty of Medicine and Health Sciences, Universitas Jambi

Department of Public Health, Faculty of Medicine and Health Sciences, Universitas Jambi

Nyimas Natasha Ayu Shafira, Department of Medical Education, Faculty of Medicine and Health Sciences, Universitas Jambi

Department of Medical Education, Faculty of Medicine and Health Sciences, Universitas Jambi

Amelia Dwi Fitri, Department of Medical Education, Faculty of Medicine and Health Sciences, Universitas Jambi

Department of Medical Education, Faculty of Medicine and Health Sciences, Universitas Jambi

References

[1] Li J, Guo K, Qiu J, Xue S, Pi L, Li X, et al. Epidemiological status, development trends, and risk factors of disability-adjusted life years due to diabetic kidney disease: A systematic analysis of Global Burden of Disease Study 2021. Chin Med J (Engl). 2025;138(5):568–578. doi:10.1097/CM9.0000000000003428.

[2] Wahidin M, Achadi A, Besral B, et al. Projection of diabetes morbidity and mortality till 2045 in Indonesia based on risk factors and NCD prevention and control programs. Sci Rep. 2024;14:5424. doi:10.1038/s41598-024-54563-2.

[3] Indonesian Renal Registry (IRR). 13th Report of Indonesian Renal Registry 2020. Jakarta: Indonesian Renal Registry; 2020. Available from: https://www.indonesianrenalregistry.org/media/laporan%20IRR%202020.pdf.

[4] International Diabetes Federation (IDF). Diabetes and Kidney Disease Report. IDF Diabetes Atlas, 11th ed. Brussels: International Diabetes Federation; 2024. Available from: https://diabetesatlas.org/resources/idf-diabetes-atlas-reports/diabetes-and-kidney-disease/.

[5] Al-Dabet MM, Shahzad K, Elwakiel A, et al. Reversal of the renal hyperglycaemic memory in diabetic kidney disease by targeting sustained tubular p21 expression. Nat Commun. 2022;13:5062. doi:10.1038/s41467-022-32477-9.

[6] Mohandes S, Doke T, Hu H, Mukhi D, Dhillon P, Susztak K. Molecular pathways that drive diabetic kidney disease. J Clin Invest. 2023;133(4):e165654. doi:10.1172/JCI165654.

[7] Efiong EE, Maedler K, Effa E, et al. Decoding diabetic kidney disease: a comprehensive review of mechanisms, biomarkers and therapeutic strategies. Metab Syndr. 2025;17:192. doi:10.1186/s13098-025-01726-4.

[8] Winkler TW, Rasheed H, Teumer A, et al. Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals. Commun Biol. 2022;5:580. doi:10.1038/s42003-022-03448-z.

[9] Tziastoudi M, Stefanidis I, Zintzaras E. The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies. Clin Kidney J. 2020;13(5):768–781. doi:10.1093/ckj/sfaa048.

[10] Karimi F, Maleki M, Movahedpour A, et al. Overview of the renin-angiotensin system in diabetic nephropathy. J Renin Angiotensin Aldosterone Syst. 2024;25:14703203241302966. doi:10.1177/14703203241302966.

[11] Rani P, Koulmane LSL, Swaminathan SM, et al. TGF-β: elusive target in diabetic kidney disease. Ren Fail. 2025;47(1):2483990. doi: 10.1080/0886022X.2025.2483990.

[12] Mazzieri A, Porcellati F, Timio F, et al. Molecular targets of novel therapeutics for diabetic kidney disease: a new era of neuroprotection. Int J Mol Sci. 2024;25(7):3969. doi:10.3390/ijms25073969.

[13] Yuan Q, Tang B, Zhang C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther. 2022;7:182. doi:10.1038/s41392-022-01036-5.

[14] Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest. 1994;93(6):2431–2437. doi:10.1172/JCI117251.

[15] Król-Kulikowska M, Abramenko N, Jakubek M, Banasik M, Kepinska M. The role of angiotensin-converting enzyme (ACE) polymorphisms in the risk of development and treatment of diabetic nephropathy. J Clin Med. 2024;13(4):995. doi:10.3390/jcm13040995.

[16] Mai M, Wang X, Chen J, et al. Association of TGF-β1, IL-4, and IL-10 polymorphisms with chronic kidney disease susceptibility: a meta-analysis. Front Genet. 2020;11:79. doi:10.3389/fgene.2020.00079.

[17] Deng L, Hoh BP, Lu D, Saw WY, Ong RTH, Kasturiratne A, et al. Dissecting the genetic structure and admixture of four geographical Malay populations. Sci Rep. 2015 Sep 23;5:14375. doi:10.1038/srep14375.

[18] Ardiansyah E, Riza A-L, Dian S, Ganiem AR, Alisjahbana B, Setiabudiawan TP, et al. Sequencing whole genomes of the West Javanese population in Indonesia reveals novel variants and improves imputation accuracy. Front Genet. 2025;15:1492602. doi:10.3389/fgene.2024.1492602. (eCollection 2024).

[19] Oktamianti P, Kusuma D, Amir V, Tjandrarini DH, Paramita A. District-level inequalities in hypertension among adults in Indonesia: a cross-sectional analysis by sex and age group. Int J Environ Res Public Health. 2022;19(20):13268. doi:10.3390/ijerph192013268.

[20] Elfiani E, Puspasari A, Arif CW, et al. Angiotensin-converting enzyme genetic polymorphism rs4343 as risk of diabetic nephropathy in Jambi-Malay population. Mol Cell Biomed Sci. 2024;8(1):37–43. doi:10.20473/mcbs.v9i1.410.

[21] Puspasari A, Elfiani E, Tarawifa S, et al. Genetic variant of TGF-β associated with decreased renal function in type II diabetes mellitus patient: single-center pilot study in Indonesia. J Med Sci (Berk Ilmu Kedokt). 2021;53(4):319–328. doi:10.19106/JMedSci005304202101.

[22] Perkumpulan Endokrinologi Indonesia (PERKENI). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia – 2021. Jakarta: PB PERKENI; 2021.

[23] Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(suppl 4S):S117–S314.

[24] National Center for Biotechnology Information (NCBI). dbSNP rs1800470 [Internet]. Bethesda (MD): U.S. National Library of Medicine; 2024 [cited 2025 Oct 29]. Available from: https://www.ncbi.nlm.nih.gov/snp/rs1800470/.

[25] National Center for Biotechnology Information (NCBI). Gene ACE — search term “rs4343” [Internet]. Bethesda (MD): U.S. National Library of Medicine; 2025 [cited 2025 Oct 29]. Available from: https://www.ncbi.nlm.nih.gov/gene/?term=rs4343.

[26] Liao LN, Li TC, Li CI, Liu CS, Lin WY, Lin CH, et al. Genetic risk score for risk prediction of diabetic nephropathy in Han Chinese type 2 diabetes patients. Sci Rep. 2019;9:19897. doi:10.1038/s41598-019-56400-3.

[27] Chan L, Nadkarni GN, Fleming F, McCullough JR, Connolly P, Mosoyan G, et al. Derivation and validation of a machine-learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease. Diabetologia. 2021;64(7):1504–1515. doi:10.1007/s00125-021-05444-0.

[28] Dong Z, Wang Q, Ke Y, Zhang W, Hong Q, Liu C, et al. Prediction of 3-year risk of diabetic kidney disease using machine learning based on electronic medical records. J Transl Med. 2022;20(1):143. doi:10.1186/s12967-022-03339-1.

Downloads

Published

29-11-2025

How to Cite

Puspasari, A., Elfiani, Maharani, C., Syauqy, A., Kusdiyah, E., Shafira, N. N. A., & Fitri, A. D. (2025). Predictive model of declining glomerular filtration rate in type 2 diabetes mellitus with poorly glycemic control: Integration of RAAS and TGFB polymorphisms with clinical risk factors in the Jambi Malay population. Proceedings Academic Universitas Jambi, 1(2), 535–544. https://doi.org/10.22437/proca.v1i2.50317

Issue

Section

RESEARCH DISSEMINATION